288 related articles for article (PubMed ID: 10201336)
1. Does a high peritoneal transport rate reflect a state of chronic inflammation?
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Perit Dial Int; 1999; 19(1):17-22. PubMed ID: 10201336
[TBL] [Abstract][Full Text] [Related]
2. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
4. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
5. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients.
van Esch S; Zweers MM; Jansen MA; de Waart DR; van Manen JG; Krediet RT
Perit Dial Int; 2004; 24(6):554-61. PubMed ID: 15559485
[TBL] [Abstract][Full Text] [Related]
6. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
[TBL] [Abstract][Full Text] [Related]
7. Dialysate hyaluronan concentration predicts survival but not peritoneal sclerosis in continuous ambulatory peritoneal dialysis.
Szeto CC; Wong TY; Lai KB; Lam CW; Lai KN; Li PK
Am J Kidney Dis; 2000 Sep; 36(3):609-14. PubMed ID: 10977794
[TBL] [Abstract][Full Text] [Related]
8. Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study.
Konings CJ; Kooman JP; Schonck M; Struijk DG; Gladziwa U; Hoorntje SJ; van der Wall Bake AW; van der Sande FM; Leunissen KM
Nephrol Dial Transplant; 2003 Apr; 18(4):797-803. PubMed ID: 12637651
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal transport characteristics with glycerol-based dialysate in peritoneal dialysis.
Smit W; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2000; 20(5):557-65. PubMed ID: 11117247
[TBL] [Abstract][Full Text] [Related]
10. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
Pilkey RM; Morton AR; Iliescu EA
Adv Perit Dial; 2001; 17():153-7. PubMed ID: 11510266
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
[TBL] [Abstract][Full Text] [Related]
13. Increased production of hyaluronan by peritoneal cells and its significance in patients on CAPD.
Lai KN; Szeto CC; Lai KB; Lam CW; Chan DT; Leung JC
Am J Kidney Dis; 1999 Feb; 33(2):318-24. PubMed ID: 10023645
[TBL] [Abstract][Full Text] [Related]
14. Calculation of 6-hour D/P creatinine ratio from the 4-hour peritoneal equilibration test. The effect of dwell duration on the results.
Mehrotra R; Khanna R; Yang TC; Kathuria P; Moore HL; Prowant BF; Nolph KD; Twardowski ZJ
Perit Dial Int; 1997; 17(3):273-8. PubMed ID: 9237289
[TBL] [Abstract][Full Text] [Related]
15. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
[TBL] [Abstract][Full Text] [Related]
16. Correlations between plasminogen activator inhibitor-1 and peritoneal transport in pediatric CCPD patients.
Lin JJ; Singhal K; Parton L; Cascio C; Patlak CS; Stewart CL
Perit Dial Int; 1995; 15(6):246-51. PubMed ID: 7578502
[TBL] [Abstract][Full Text] [Related]
17. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
Passadakis PS; Thodis ED; Panagoutsos SA; Selisiou CA; Pitta EM; Vargemezis VA
Adv Perit Dial; 2000; 16():2-6. PubMed ID: 11045251
[TBL] [Abstract][Full Text] [Related]
18. A simple assessment of peritoneal transport in stable continuous ambulatory peritoneal dialysis patients.
Lai KN; Szeto CC; Ho KK; Yu AW; Mak TW; Lam CW
Am J Nephrol; 1998; 18(4):311-7. PubMed ID: 9653835
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal fluid transport in CAPD patients with different transport rates of small solutes.
Sobiecka D; Waniewski J; Weryński A; Lindholm B
Perit Dial Int; 2004; 24(3):240-51. PubMed ID: 15185772
[TBL] [Abstract][Full Text] [Related]
20. Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients.
Kang DH; Yoon KI; Choi KB; Lee R; Lee HY; Han DS; Cho EY; Lee JH
Nephrol Dial Transplant; 1999 Jul; 14(7):1715-22. PubMed ID: 10435882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
